LPL Financial’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.49M | Buy |
197,931
+83,050
| +72% | +$3.64M | ﹤0.01% | 2042 |
|
|
2025
Q4 | $4.44M | Buy |
114,881
+7,256
| +7% | +$277K | ﹤0.01% | 2631 |
|
|
2025
Q3 | $3.8M | Buy |
107,625
+54,650
| +103% | +$1.98M | ﹤0.01% | 2726 |
|
|
2025
Q2 | $1.91M | Sell |
52,975
-16,166
| -23% | -$536K | ﹤0.01% | 3170 |
|
|
2025
Q1 | $2.15M | Buy |
69,141
+45,236
| +189% | +$1.43M | ﹤0.01% | 2893 |
|
|
2024
Q4 | $610K | Sell |
23,905
-2,859
| -11% | -$75.8K | ﹤0.01% | 3917 |
|
|
2024
Q3 | $757K | Sell |
26,764
-18,294
| -41% | -$507K | ﹤0.01% | 3653 |
|
|
2024
Q2 | $1.19M | Buy |
45,058
+16,207
| +56% | +$449K | ﹤0.01% | 3093 |
|
|
2024
Q1 | $876K | Buy |
28,851
+8,327
| +41% | +$245K | ﹤0.01% | 3307 |
|
|
2023
Q4 | $577K | Buy |
20,524
+5,241
| +34% | +$144K | ﹤0.01% | 3555 |
|
|
2023
Q3 | $415K | Sell |
15,283
-3,555
| -19% | -$106K | ﹤0.01% | 3633 |
|
|
2023
Q2 | $579K | Buy |
18,838
+296
| +2% | +$10K | ﹤0.01% | 3316 |
|
|
2023
Q1 | $668K | Buy |
18,542
+10,984
| +145% | +$407K | ﹤0.01% | 3109 |
|
|
2022
Q4 | $299K | Sell |
7,558
-2,337
| -24% | -$97.5K | ﹤0.01% | 3651 |
|
|
2022
Q3 | $398K | Buy |
9,895
+763
| +8% | +$32.6K | ﹤0.01% | 3353 |
|
|
2022
Q2 | $384K | Buy |
9,132
+2,201
| +32% | +$90.2K | ﹤0.01% | 3430 |
|
|
2022
Q1 | $270K | Sell |
6,931
-789
| -10% | -$31K | ﹤0.01% | 3643 |
|
|
2021
Q4 | $308K | Buy |
+7,720
| New | +$300K | ﹤0.01% | 3664 |
|
|
2021
Q1 | – | Sell |
-5,694
| Closed | -$285K | – | 4137 |
|
|
2020
Q4 | $285K | Sell |
5,694
-14,056
| -71% | -$596K | ﹤0.01% | 3243 |
|
|
2020
Q3 | $831K | Buy |
19,750
+10,867
| +122% | +$466K | ﹤0.01% | 2089 |
|
|
2020
Q2 | $431K | Buy |
+8,883
| New | +$440K | ﹤0.01% | 2527 |
|
Other funds holding RPRX
